Microsoft

In Print

Premium

Bioinformatics Tool-Related Papers of Note, February 2009

People Transfer

Premium

Fate Therapeutics names Dan Shoemaker as CTO

Speakers at the Future of Genomic Medicine conference tempered their enthusiasm about the field by highlighting a number of obstacles standing in the way of making whole-genome studies a standard part of medical care.

Linguamatics plans this year to continue building a customer base among large pharmaceutical firms, while Bioalma is eyeing the academic market to help drive growth in 2009.

People Transfer

Premium

Thomas Fekete to direct Johns Hopkins' INBT; UW TechTransfer names Entrepreneur Residents and Advisors

Direct-to-consumer genetic testing companies have based their products on what scientists have accomplished, but the caveat is that the science is still in its early days.

Both companies are offering users of second-generation sequencing systems new tools to select portions of the genome for targeted resequencing but have optimized their products for different sequencing platforms.

Funding from the National Institutes of Health for all proteomics-related research shrank by almost 3 percent in fiscal 2008, according to an analysis of NIH data by ProteoMonitor.

In the wake of the announcement that the working draft of the human genome sequence is done, BioInform spoke with four informatics

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.